Moreno-Camacho A, López-Vélez R, Muñoz Sanz A, Labarga-Echevarría P
Hospital Clínic Universitari, Barcelona.
Enferm Infecc Microbiol Clin. 1998;16 Suppl 1:52-60.
Intestinal parasite infections are very frequent in HIV patients with severe immunodeficiency (CD4 < 100/mm3) causing chronic diarrhea and malabsorption in the majority of cases. The most frequent microorganisms are microsporidia and Cryptosporidium parvum while Cyclospora cayetanensis and Isospora belli are more prevalent in subtropical and tropical areas and rare in industrialized areas. The diagnosis can be obtained by stool examination (differences in size and form of cysts), although microsporidia is frequently demonstrated by intestinal biopsy and/or duodenal aspirate. The treatment with cotrimoxazole for C. cayetanensis and I. belli is very effective and does not present any problems in the acute phase, however, due to a high percentage of relapses the treatment must be maintained while the patient is in a severe immunodeficiency state. E. intestinalis usually responds satisfactorily to albendazole while E. bieneusi is resistant to some drugs except in some cases (albendazole, atovaquone ad fumagillin). C parvum is also resistant to most medicaments but shows an adequate or partial clinical: response to paramomicine (< 50%). When there is no response, it is advised to administer octreotide since in half the cases the response is positive either total or partial. Nowadays with the use of protease inhibitors in the antiretroviral treatment a decrease in the incidence of these infections has been observed (microsporidia and C. parvum) even in the stools samples taken from the patients who had them before. As primary prophylaxis for C. parvum, it is better to avoid been exposed to the microorganism taking into account the 1997 preventive measures recommended by the USPHS/IDSA Prevention of Opportunistic Infections Working Group. The coinfection Leishmania-HIV is frequent in the mediterranean area. The most common specie is L. infantum. The incidence is most frequent in immunosuppressed patients (CD4 < 200 mm3) and in parenteral drug addicts. The symptomatology is similar to the one from immunocompetent patients, although in some cases it appears to be subclinical. A chronic development with relapses is frequent. The most effective diagnostic method for the finding of the parasites is thru bone marrow puncture and the culture in Novy-McNeal-Nicolle (NNN) medium. Serological tests have a low sensibility and the PCR is useful in asymptomatic cases, for therapeutical control and in relapses. The treatment is similar to that of immunocompetent patients, using primarily antimonials or amphotericine B (standard or lipid or liposomal forms). Relapses are very frequent, therefore, it is important to perform a secondary prophylaxis. However, no treatment has been completely effective. Mortality rate is high (approximately 25%) during the first month after diagnosis. This fact may be related to the severe immunodeficiency state and/or to the toxicity of the drugs used. The main priority for the future is to find a first line treatment with higher efficacy, decrease in relapses and a lower toxicity.
肠道寄生虫感染在免疫严重缺陷(CD4<100/mm³)的HIV患者中非常常见,多数情况下会导致慢性腹泻和吸收不良。最常见的微生物是微孢子虫和微小隐孢子虫,而卡耶塔环孢子球虫和贝氏等孢球虫在亚热带和热带地区更为普遍,在工业化地区则较为罕见。诊断可通过粪便检查(囊肿大小和形态的差异)获得,不过微孢子虫常通过肠道活检和/或十二指肠抽吸物来证实。用复方新诺明治疗卡耶塔环孢子球虫和贝氏等孢球虫非常有效,在急性期不存在任何问题,然而,由于复发率较高,在患者处于严重免疫缺陷状态时必须持续治疗。肠内微孢子虫通常对阿苯达唑反应良好,而比氏微孢子虫除某些情况外(阿苯达唑、阿托伐醌和烟曲霉素)对一些药物耐药。微小隐孢子虫对大多数药物也耐药,但对巴龙霉素有适当或部分临床反应(<50%)。当无反应时,建议使用奥曲肽,因为半数病例会有完全或部分阳性反应。如今,在抗逆转录病毒治疗中使用蛋白酶抑制剂后,已观察到这些感染(微孢子虫和微小隐孢子虫)的发生率有所下降,即使在之前感染过的患者的粪便样本中也是如此。作为微小隐孢子虫的一级预防,考虑到美国公共卫生署/美国感染病学会机会性感染预防工作组1997年推荐的预防措施,最好避免接触该微生物。利什曼原虫-HIV合并感染在地中海地区很常见。最常见的种类是婴儿利什曼原虫。发病率在免疫抑制患者(CD4<200mm³)和静脉注射吸毒者中最高。症状与免疫功能正常患者相似,不过在某些情况下似乎是亚临床的。常有慢性进展并伴有复发。发现寄生虫最有效的诊断方法是通过骨髓穿刺并在诺维-麦克尼尔-尼科尔(NNN)培养基中培养。血清学检测敏感性较低,PCR在无症状病例、治疗监测和复发情况中有用。治疗与免疫功能正常患者相似,主要使用锑剂或两性霉素B(标准剂型、脂质体剂型或脂质剂型)。复发非常频繁,因此进行二级预防很重要。然而,尚无治疗完全有效。诊断后第一个月的死亡率很高(约25%)。这一事实可能与严重的免疫缺陷状态和/或所用药物的毒性有关。未来的主要优先事项是找到一种疗效更高、复发率降低且毒性更低的一线治疗方法。